Lymphoma, B Cell: Clinical Trials

4 trials for Lymphoma, B Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Terminated 1
Phase 11Recruiting 1

Follow Lymphoma, B Cell: new trials by email Literature Review of Lymphoma, B Cell trials Research Report on Lymphoma, B Cell

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
UB-VV400, Rapamycin (sirolimus) - Lymphoma, B Cell, Lymphoma Non-Hodgkin
Phase 1 / Phase 2RecruitingUmoja Biopharma2742026-11-012026-11-10
DepoCyt for Active Lymphomatous or Leukemic Meningitis
cytarabine liposome injection - Neoplastic Meningitis, Lymphoma, B Cell
Phase 2TerminatedDuke University42006-06-012013-06-17
Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
high dose methotrexate, high dose cytarabine, radiotherapy - Lymphoma, B Cell
Phase 2CompletedInternational Extranodal Lymphoma Study Group (IELSG)792003-07-012015-03-30
Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma
rituximab, CHOP, intrathecal methotrexate - Lymphoma, B Cell
Phase 2CompletedInternational Extranodal Lymphoma Study Group (IELSG)642000-11-012009-07-22

Narrower conditions

Lymphoma, B-Cell (4)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Meningeal Carcinomatosis (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Lymphoma (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Central Nervous System Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Meningeal Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)

Interventions

Radiotherapy (2)  ·  Cytarabine (1)  ·  Methotrexate (1)  ·  Rituximab (1)  ·  Sirolimus (1)

Sponsors

International Extranodal Lymphoma Study Group (IELSG) (2)  ·  Duke University (1)  ·  Umoja Biopharma (1)

Countries

Switzerland (2)  ·  United States (2)

Top investigators

Emanuele Zucca, MD (2)  ·  Andreas Sarris, MD (1)  ·  Andres JM Ferreri, MD (1)  ·  David Rizzieri, MD (1)  ·  Luke Walker, MD (1)  ·  Mary Gospodarowicz, MD (1)  ·  Michele Reni, MD (1)  ·  Umberto Vitolo, MD (1)

Results publications

PMID 19767089